Critical Role of Nrf2 in Innate Immune Response and Survival During Sepsis
Critical Role of Nrf2 in Innate Immune Response and Survival During Sepsis
批准号:
8124734
负责人:
Shyam Biswal
金额:
$6.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2011-05-31
关键词:
Adoptive TransferAffectAntibiotic TherapyAntioxidantsApoptosisAttenuatedB-LymphocytesBone MarrowCD4 Positive T LymphocytesCellsCessation of lifeDataDevelopmentDoseDrug Administration RoutesEndotoxinsEquilibriumEvaluationGene ExpressionGenerationsGenesGlutathioneHematopoieticHemeHourHydrogen PeroxideIRAK1 geneIRF3 geneImmuneImmune responseInfiltrationInflammationInflammatoryInflammatory ResponseIntegration Host FactorsInterleukin-6InterventionKidneyLeadLigationLightLinkLiverLungLymphocyteMediatingMembrane MicrodomainsModelingMusMyelogenousNADPH OxidaseOrganOxidation-ReductionOxidative StressOxygenasesPathogenesisPathologicPathologyPathway interactionsPeritoneal MacrophagesPersonsPlayPredispositionPuncture procedureRag1 MouseRegulationRelative (related person)Research PersonnelRoleSepsisSeptic ShockSerumSignal PathwaySignal TransductionSpleenStressT-LymphocyteTLR4 geneTRAF6 geneTestingTimeTransgenic MiceUnited StatesWild Type Mouseapoptosis in lymphocytesbZIP Domainbasecaspase-3chemokinecytokinedrug efficacygene inductionglutathione peroxidaseheme oxygenase-1human GCLC proteinhuman GCLM proteinimprovedinfancyinhibitor/antagonistintraperitonealmacrophagemortalityneutrophilnovelnovel strategiesnuclear factor-erythroid 2overexpressionperipheral bloodreconstitutionresponsesmall moleculetoll-like receptor 4traffickingtranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term objective is to understand the host factors that regulate the systemic inflammation and pathogenesis of sepsis, which affects 750,000 persons every year in United States alone and causes high mortality worldwide. We recently discovered a novel host factor, nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) that plays a critical role in determining susceptibility to sepsis by regulating a compensatory pathway that controls the induction of protective cellular antioxidants. Nrf2 is a basic leucine zipper transcription factor that regulates the expression of antioxidant genes including the glutathione pathway and heme oxygenase in response to oxidative and inflammatory stress. Global disruption of Nrf2 (Nrf2 -/-) dramatically decreased survival after cecal ligation and puncture (CLP) and endotoxin treatment relative to wild-type mice (Nrf2 +/+). We hypothesize that Nrf2 regulates a host compensatory mechanism that causes transcriptional induction of antioxidant genes, which determines survival during sepsis. Disruption of Nrf2-dependent compensatory antioxidant pathways increases mortality by exaggerating the innate immune response and predisposing lymphocytes to increase apoptosis. This proposal will shed light on the Nrf2-dependent regulation of immunopathogenesis of sepsis and survival after CLP and strives to develop an intervention strategy targeting Nrf2 with a novel small-molecule activator. Specific Aim 1: To test the hypothesis that Nrf2 determines survival after CLP by protecting against deregulation of innate immune response by maintaining cellular redox balance. Specific Aim 2: To test the hypothesis that Nrf2 improves survival after CLP by attenuating apoptosis of lymphocytes. Specific Aim 3: To test the hypothesis of intervening sepsis by increasing Nrf2 activity with a small-molecule activator. The immunopathogenesis of sepsis remains poorly understood. Nrf2 provides a novel link between the regulation of oxidative stress, the innate immune response.and survival during sepsis. These studies may lead to the development of novel strategies based on Nrf2 for intervening in sepsis and improving survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurotoxicity due to Environmental complex Metal Mixtures Exposure
-
批准号:10591120
-
项目类别:
-
资助金额:$242.16万
-
财政年份:2022
-
负责人:Shyam Biswal
-
依托单位:
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
-
批准号:9897626
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2016
-
负责人:Shyam Biswal
-
依托单位:
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
-
批准号:9262182
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2016
-
负责人:Shyam Biswal
-
依托单位:
Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance
-
批准号:9275991
-
项目类别:
-
资助金额:$56.23万
-
财政年份:2016
-
负责人:Shyam Biswal
-
依托单位:
Harmful Constituents and Respiratory Effects of Waterpipe Smoke
-
批准号:9185357
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2016
-
负责人:Shyam Biswal
-
依托单位:
Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance
-
批准号:9098288
-
项目类别:
-
资助金额:$55.66万
-
财政年份:2016
-
负责人:Shyam Biswal
-
依托单位:
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
-
批准号:9107950
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2016
-
负责人:Shyam Biswal
-
依托单位:
Mechanistic evaluation of broccoli sprout extract in preclinical COPD models
-
批准号:8628259
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2014
-
负责人:Shyam Biswal
-
依托单位:
Pulmonary effects of biomass fuel indoor PM from rural India
-
批准号:8210689
-
项目类别:
-
资助金额:$6.61万
-
财政年份:2012
-
负责人:Shyam Biswal
-
依托单位:
Pulmonary effects of biomass fuel indoor PM from rural India
-
批准号:8459425
-
项目类别:
-
资助金额:$5.06万
-
财政年份:2012
-
负责人:Shyam Biswal
-
依托单位:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
-
批准号:8403458
-
项目类别:
-
资助金额:$4.05万
-
财政年份:2012
-
负责人:Shyam Biswal
-
依托单位:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
-
批准号:8549297
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2012
-
负责人:Shyam Biswal
-
依托单位:
Nrf2 Dependent Regulation of Oxidative Stress in Asthma
-
批准号:8294887
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2011
-
负责人:Shyam Biswal
-
依托单位:
Developing Nrf2 as a target for treatment of corticosteroid resistance in COPD
-
批准号:8262688
-
项目类别:
-
资助金额:$45.26万
-
财政年份:2011
-
负责人:Shyam Biswal
-
依托单位:
Developing Nrf2 as a target for treatment of corticosteroid resistance in COPD
-
批准号:8073287
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2011
-
负责人:Shyam Biswal
-
依托单位:
Regulation of Tumorigenesis and therapeutic resistance by Nrf2 in lung cancer
-
批准号:8212445
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2010
-
负责人:Shyam Biswal
-
依托单位:
Enhancing Nrf2 by Sulforaphane Treatment in COPD
-
批准号:8020599
-
项目类别:
-
资助金额:$108.72万
-
财政年份:2010
-
负责人:Shyam Biswal
-
依托单位:
Regulation of Tumorigenesis and therapeutic resistance by Nrf2 in lung cancer
-
批准号:8412791
-
项目类别:
-
资助金额:$45.74万
-
财政年份:2010
-
负责人:Shyam Biswal
-
依托单位:
Discovering Nrf2 inhibitors to enhance cancer chemotherapy and radiotherapy
-
批准号:8011293
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2010
-
负责人:Shyam Biswal
-
依托单位:
Enhancing Nrf2 by Sulforaphane Treatment in COPD
-
批准号:8319493
-
项目类别:
-
资助金额:$193.61万
-
财政年份:2010
-
负责人:Shyam Biswal
-
依托单位:
海外基金